MedPath

SPEDRA 200 mg comprimidos

SPEDRA 200 mg comprimidos

Commercialized
Register Number

113841009

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jan 9, 2014

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number113841009
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

AVANAFILOActive
Quantity: 200 mg
Name: AVANAFILO

ATC CLASSIFICATION (3)

G04B
G04BE
G04BE10

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.